drugset / Trial / NCT00385385

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

NCT00385385

Phase 2 Unknown 72 enrolled ActivBiotics
RandomizedParallel-groupDouble-blind

Summary

The objective of this study is to evaluate an antibiotic therapy called Rifalazil to determine its effect on hardening of the carotid arteries.

Timeline

Start
2006-10
Primary completion
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Rifalazil Small molecule